health-gerresheimer provider logo

Enabling Cancer Therapy at Home

Join Gerresheimer's challenge to extend the healthcare value chain and provide cancer patients with the best possible therapy at home. Create or apply digital services and solutions that enhance home care for cancer patients, addressing the unmet needs of stakeholders from the complex healthcare system.

#DecentralizedTherapy #CancerHomeCare #PatientEmpowerment

  • ✅ Completed
  • 🏁 Winner

    Congratulations to Monti for winning the challenge!

  • 🏆 Prize

    EUR 5,000 prize pool + joint pilot project + potential partnership, investment or business building

  • 🌎 Scope

    International - open to participants from all over the world

  • ❓ Q&A Call
  • 🧬HealthTech

    This challenge is part of the HealthTech program

The following opportunity areas have been identified as promising for developing innovative solutions. While these areas are intended to inspire participants, you can also go with alternative approaches that meet the criteria and guidelines provided.

What are the focus areas?

All of the 6Ps can be a good starting point for services/ solutions to push home care for cancer patients. In the best case you can target as many of the 6Ps as possible to increase the chances of success.

Patients

Challenges

  • Limited access to home therapy and home care due to lack of awareness, cost, or insurance coverage.
  • Fear or discomfort with self-administration of medication.
  • Difficulty managing symptoms and side effects of cancer and its treatments at home.
  • Lack of communication and collaboration between patients and healthcare professionals.

Guiding question: How can we empower cancer patients to take control of their care at home and manage their symptoms safely and effectively?

Physicians

Challenges

  • Physicians concerns about safety when administered at home.
  • Limited time and resources to support patients receiving care at home, including monitoring symptoms and adjusting treatment plans.
  • Limited access to patient data and communication channels outside of the hospital or clinic.
  • Difficulty coordinating care across multiple providers and settings.
  • Ensuring appropriate patient selection and monitoring for use of the device and medication
  • Balancing the benefits and risks of the device and medication with other available treatment options for their patients.

Guiding question: How can we provide physicians with the necessary tools and resources to effectively support cancer patients receiving care at home and/or help identify which patients would?

Payers

Challenges

  • High costs of cancer care, including hospital stays and medical equipment, for payers and patients.
  • Ensuring positive impact on overall healthcare costs and utilization patterns.
  • Ensuring appropriate utilization management to prevent overuse or misuse of the device.

Guiding question: How can we incentivize payers to invest in home care and decentralized therapy for cancer patients while demonstrating the cost-effectiveness of these approaches?

Pharma

Challenges

  • Ensuring appropriate patient selection and monitoring for use of the device and medication.
  • Limited access to patient data outside of the hospital or clinic.
  • Difficulty adapting to changing market dynamics and regulatory requirements.
  • Manufacturing and distribution challenges related to the medication

Guiding question: How can the device and digital solution provide value to the pharmaceutical industry in terms of improved patient outcomes, increased market share, or other strategic objectives?

Providers

Challenges

  • Ensuring compliance with healthcare policies and guidelines related to the use of the device and medication
  • Ensuring appropriate monitoring and management of any adverse effects or complications related to the device or medication
  • Ensuring adequate training and resources for staff on the proper use of the device and medication
  • Integration of the device into existing clinical workflows and processes for cancer care
  • Ensuring appropriate communication and coordination with other healthcare providers and payors regarding the use of the device and medication

Guiding question: What are the current workflows and processes for cancer care in hospitals, and how can our device fit into these workflows in a seamless and efficient way?

Policymakers

Challenges

  • Limited policies and regulations supporting home care and decentralized therapy for cancer patients.
  • Limited resources and infrastructure for supporting home care and decentralized therapy.
  • Limited awareness and education among policymakers and the public about the benefits of home care and decentralized therapy.

Guiding question: How can we support the development of policies and regulations that promote home care and decentralized therapy for cancer patients, while also increasing awareness and education about their benefits?

For all the creative minds: Do You have solutions in areas not yet defined but will have a big impact towards patient life?